Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the Government of Canada’s decision to advise citizens not to use face masks that contain graphene due to the possibility that they could inhale graphene particles which may be a health risk; and if he will make an assessment of whether a similar warning is necessary in the UK.

The Medicines and Healthcare products Regulatory Agency (MHRA) have not received any reported adverse events relating to medical and surgical face masks containing graphene. The MHRA continues to review all available information and will issue safety information as and when necessary.